Vol 16; Issue 11; Novem­ber 2018

BioSpectrum (India) - - BIO MAIL -

R&D in­vest­ments

It is a very positive sign that In­dian pharma com­pa­nies are ramp­ing up their R&D spend and tar­get­ing in­no­va­tion as their line of strat­egy. The com­ing years will keep them in good stead to cap­ture new op­por­tu­ni­ties in the de­vel­oped mar­ket.

- Gau­rav Jain, New Delhi

Vac­cine con­tam­i­na­tion

This re­cent po­lio vac­cine con­tam­i­na­tion issue has surely threat­ened to change In­dia’s po­lio-free sta­tus. The ma­jor con­cern now is that hereon there should be greater trans­parency in com­mu­ni­cat­ing the de­vel­op­ments around this in­ci­dent.

- Shilpa Jha, Pune

Ayush­man Bharat Rolling

Although the gov­ern­ment re­al­izes the need to in­crease pub­lic spend­ing in health­care, it would be im­por­tant to en­sure that the spend­ing is done in the right man­ner. We need our own solutions to our own prob­lems which are best suited to our pop­u­la­tion and our sys­tems.

- Dr De­braj Shome, Mumbai

Promis­ing IoT

The In­ter­net of Things (IoT)-en­abled con­nec­tiv­ity has the po­ten­tial to cat­a­pult the ail­ing health­care sys­tem into an in­te­grated, ef­fi­cient and pa­tient-cen­tric sys­tem. It is po­si­tioned to usher in a new era of holis­tic health­care solutions.

- Dr Taran Me­hta, Bengaluru

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.